• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-
-

2010 Warning Letters

Recently Posted | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

Warning Letters issued in 2010

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

Posted on April 19, 2010

Letter Issue Date Company Name Issuing Office Subject Close Out Date
April 08, 2010 Bryant Ranch Prepack Inc. Los Angeles District Office New Drug/Labeling/Misbranded/Adulterated Not Issued *
April 08, 2010 The Children's Hospital Assoc. Transfusion Medicine Services Denver District Office CGMP for Blood & Blood Products/Adulterated August 08, 2011
April 07, 2010 Wake Forest University Baptist Medical Center Atlanta District Office Device/Adulterated Not Issued *
April 06, 2010 Pure Med Spa Center for Drug Evaluation and Research Lipodissolve/False & Misleading Claims/Misbranded Not Issued *
April 06, 2010 Aloha Medicinals Inc. San Francisco District Office New Animal Drug/Labeling/Misbranded/Adulterated Not Issued *
April 05, 2010 Innovative Directions in Health Center for Drug Evaluation and Research Lipdissolve/False & Misleading Claims/Misbranded February 10, 2011
April 05, 2010 Spa 35 Center for Drug Evaluation and Research Lipodissolve/False & Misleading Claims/Misbranded May 21, 2010
April 05, 2010 Monarch Med Spa Center for Drug Evaluation and Research Lipodissolve/False & Misleading Claims/Misbranded May 21, 2010
April 05, 2010 All About You Medspa, LLC Center for Drug Evaluation and Research Lipodissolve/False & Misleading Claims/Misbranded May 21, 2010
April 05, 2010 Medical Cosmetic Enhancements Center for Drug Evaluation and Research Lipodissolve/False & Misleading Claims/Misbranded May 21, 2010


 

Contact FDA

301-796-8490
FDA's Office of Critical Path Programs
-
-
-